Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Medication Storage and Labeling Deficiencies

Los Angeles, California Survey Completed on 05-09-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors identified that insulin pens belonging to a resident with diagnoses including hemiplegia, type 2 diabetes, COPD, and epilepsy were found opened and not discarded in the medication storage room. The resident required maximal assistance with activities of daily living and had moderately impaired cognitive skills. During observation, a licensed vocational nurse confirmed that the insulin pens should have been discarded and acknowledged that failure to do so could result in an infection control issue. Additionally, a bottle of valproic acid prescribed to another resident with epilepsy, type 2 diabetes, schizophrenia, and aphonia was found in the medication cart with an illegible label. This resident had severely impaired cognitive skills and required moderate assistance with daily activities. The same nurse confirmed that all medications should have legible labels and that an illegible label could lead to medication errors and uncertainty about medication ownership. The facility's policy required medications and biologicals to be stored safely, securely, and properly, in accordance with manufacturer or supplier recommendations.

An unhandled error has occurred. Reload 🗙